Recent developments to share with you

Good News! Kangchuanji Helps Partner Achieve China's First Generic Drug Consistency Evaluation for Co-Trimoxazole Injection

According to the drug approval information released by NMPA, the Co-Trimoxazole Injection (specification: 5ml containing sulfamethoxazole 0.4g and trimethoprim 80mg) manufactured by Nanjing Jinling Pharmaceutical Factory of Jinling Pharmaceutical Co., Ltd. has passed the national generic drug quality and efficacy consistency evaluation (referred to as "consistency evaluation"), becoming the first manufacturer in China to have this intravenous formulation approved through the consistency evaluation. Kangchuanji provided R&D-related services for this product.

2024-08-21

Good News! Kangchuanji Helps Partner Achieve China's First Approval for Olmesartan Medoxomil Orally Disintegrating Tablets

According to the drug approval information released by NMPA, Guangzhou Yipinhong Pharmaceutical Co., Ltd. has obtained approval for its Olmesartan Medoxomil Orally Disintegrating Tablets. This product is the first generic version and the first to pass consistency evaluation in China. Kangchuanji provided services for this product.

2024-08-19

Jiuzhou Pharmaceutical Included in the FTSE4Good Index Series for the First Time

Recently, FTSE Russell confirmed that Zhejiang Jiuzhou Pharmaceutical Co., Ltd. has been independently assessed against the FTSE4Good criteria and has met the requirements to become a constituent of the FTSE4Good Index Series.

2024-08-19

Yehui Medicine and Kangchuanji Hold "Trusted Partner" Plaque Presentation Ceremony

Recently, Kangchuanji helped Yehui Medicine achieve implied approval for its BN104 Clinical Trial Application (IND) in China. On the morning of September 5, a delegation from Yehui Medicine led by CEO Hua Ye visited our company for an exchange and held a "Trusted Partner" plaque presentation ceremony. Attendees included Hua Ye (CEO of Yehui Medicine), Wang Peng (Senior Director of Pharmaceutical Sciences), Zhou Yongsheng (Senior Manager of Formulation), Gong Yujing (Manager of Analysis), as well as Yin Lifang (General Manager of Kangchuanji), and Deputy General Managers Zhu Chunli, Yang Debao, Chen Jintuo, and Hu Haijian.

2023-09-11

School of Pharmacy, China Pharmaceutical University Holds Plaque Presentation Ceremony with Nanjing Kangchuanji for Graduate Employment Base

At the beginning of the event, Yin Lifang, General Manager of our company, led the visitors on a “Welcome to Kangchuanji” tour, giving a detailed introduction to the company’s development history, operational scale, talent pool, and main business areas. Subsequently, Zhang Shiying, Secretary of the Party Committee of the School of Pharmacy, introduced the school’s basic situation in terms of its history, number of faculty and students, and research capabilities. Meng Xiangkang, Deputy Secretary of the Party Committee of the School, shared the scale of the 2023 graduating class and the school’s current overall employment situation. Both sides conducted in-depth discussions on industry-university-research collaboration, student internships and apprenticeships, and graduate employment, further clarifying their intentions and exploring ways to cooperate.

2023-04-03

< 1234 >